28 December 2011

[Former B player] Barça non repechage to Oriol Romeu

Barca has already decided that this summer will not execute the option to repurchase by the middle of Chelsea.


Oriol Romeu consolidation as one of the most important players in the Chelsea midfield is not going unnoticed in the FC Barcelona or the environment club. It has been much speculation in recent days about the possibility of exercising the option Barca repurchase signed when the player was transferred to the London club. However, as has been told Mundo Deportivo, the sports officials of the entity Barca have already made the decision not to soccer playoffs at least this summer. Despite the expected output of Seydou Keita, one who is discarded to make some money through a transfer, the experts consider that so far no 'overbooking' in the Barca midfield and the situation does not vary much (there was a plague injured or something similar), Oriol Romeu remain at Chelsea next season. Xavi, Iniesta, Cesc, Busquets, Thiago, Mascherano ... all of them, plus some of the subsidiary may act in the wide field and close the door now.

The midfielder from FC Barcelona quarry entity committed to the Stamford Bridge for four seasons. By transfer, FC Barcelona last summer saw about 5 million euros. In the purchase agreement was established between entities an option to repurchase the squad. If this option is exercised at the end of the first year of Romeu at Chelsea, Barça would have to pay 10 million euros. If carried out at the end of the second season, the amount would rise to 15 million euros.

That Barça will not Oriol Romeu playoffs does not mean it does not value what you are doing the young footballer. The midfielder started as a deputy and his arrival coincided with the ownership of the overall performance improvement Chelsea habíacomenzado not a good season and was slowly improving. Also in the Champions League competition has been determined to have completed the English as group despite the irregularities that had football in his home. (via MD)